Progressive myoclonic epilepsy
ORPHA:98261Lafora disease
ORPHA:501Progressive myoclonic epilepsy type 3
ORPHA:263516Progressive myoclonic epilepsy type 5
ORPHA:402082Progressive myoclonic epilepsy type 6
ORPHA:280620Progressive myoclonic epilepsy type 7
ORPHA:435438Progressive myoclonic epilepsy type 8
ORPHA:424027Progressive myoclonic epilepsy type 9
ORPHA:457265Progressive myoclonic epilepsy with dystonia
ORPHA:35259646,XX difference of sex development
ORPHA:298246,XX difference of sex development induced by androgens excess
ORPHA:9807846,XX difference of sex development induced by endogenous maternal-derived androgen
ORPHA:32509346,XX difference of sex development induced by exogenous maternal-derived androgen
ORPHA:32509946,XX difference of sex development induced by fetal androgens excess
ORPHA:9077646,XX difference of sex development induced by fetoplacental androgens excess
ORPHA:32506146,XX difference of sex development induced by maternal-derived androgen
ORPHA:9114446,XX difference of sex development-anorectal anomalies syndrome
ORPHA:297346,XX difference of sex development-skeletal anomalies syndrome
ORPHA:297546,XX disorder of gonadal development
ORPHA:32505546,XX ovotesticular difference of sex development
ORPHA:213846,XX testicular difference of sex development
ORPHA:39346,XY difference of sex development
ORPHA:9808546,XY difference of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency
ORPHA:75246,XY difference of sex development due to 5-alpha-reductase 2 deficiency
ORPHA:75346,XY difference of sex development due to a cholesterol synthesis defect
ORPHA:32551146,XY difference of sex development due to a defect in testosterone metabolism by peripheral tissue
ORPHA:9808646,XY difference of sex development due to a testosterone synthesis defect
ORPHA:9078346,XY difference of sex development due to adrenal and testicular steroidogenesis defect
ORPHA:9078646,XY difference of sex development due to impaired androgen production
ORPHA:32535746,XY difference of sex development due to isolated 17,20-lyase deficiency
ORPHA:9079646,XY difference of sex development due to testicular 17,20-desmolase deficiency
ORPHA:44308746,XY difference of sex development due to testicular steroidogenesis defect
ORPHA:9078746,XY difference of sex development induced by maternal exposure to endocrine disruptors
ORPHA:32553746,XY difference of sex development of endocrine origin
ORPHA:32535146,XY difference of sex development of gynecological interest
ORPHA:32563246,XY difference of sex development-adrenal insufficiency due to CYP11A1 deficiency
ORPHA:16855846,XY difference of sexual development due to dihydrotestosterone backdoor pathway biosynthesis defect
ORPHA:44309046,XY disorder of gonadal development
ORPHA:32511846,XY ovotesticular difference of sex development
ORPHA:325345Anterior cutaneous nerve entrapment syndrome
ORPHA:51890Anterior segment developmental anomaly
ORPHA:88632Anterior segment developmental anomaly of genetic origin
ORPHA:522540Anterior segment developmental anomaly with extraocular manifestations
ORPHA:519276Anterior segment developmental anomaly without extraocular manifestations
ORPHA:98634Brain abnormalities-severe developmental delay-facial dysmorphism-intellectual disability syndrome
ORPHA:664410Brain abnormalities-severe developmental delay-facial dysmorphism-intellectual disability syndrome due to MEF2C mutation
ORPHA:664416CCNK-related neurodevelopmental disorder-severe intellectual disability-facial dysmorphism syndrome
ORPHA:600668CDK13-related developmental delay-intellectual disability-facial dysmorphism-congenital heart defects syndrome
ORPHA:646278